Intrinsic Value of S&P & Nasdaq Contact Us

AC Immune S.A. ACIU NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • CH • USD

SharesGrow Score
52/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.00
+122.9%

Over the last 12 months, insiders have made 8 transactions in ACIU stock — 0 buys (valued at RSU Award) and 0 sells (valued at RSU Award).

ACIU Insider Ownership

Top Holder
-
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 0%
Sell 0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-18 Zuegel Martin Director Unknown 32,061 $1.84 $58.99K
2026-03-20 Donati Piergiorgio Chief Operating Officer Unknown 89,552 $3.03 $271.34K
2026-03-18 Twyman Roy Ervin Director Unknown 43,299 $1.84 $79.67K
2026-03-18 June Carl Howard Director Unknown 43,299 $1.84 $79.67K
2026-03-18 Buetler Monika Director Unknown 46,392 $1.84 $85.36K
2026-03-18 Roberts Christopher James Chief Financial Officer Unknown 89,552 $3.03 $271.34K
2026-03-18 Pfeifer Andrea Chief Executive Officer Unknown 644,444 $2.03 $1.31M
2026-03-18 Aguiar-lucander Renee Director Unknown 32,061 $1.84 $58.99K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message